p21Waf1/Cip1 and p53 are downstream effectors of protein kinase C delta in tumor suppression and differentiation in human colon cancer cells

International Journal of Cancer

Volumn 113, Issue 1, 2005, Pages 42-53

  Perletti, Gianpaolo ^a   Marras, Emanuela ^a   Dondi, Davide ^a   Osti, Daniela ^a   Congiu, Terenzio ^a   Ferrarese, Roberto ^a   De Eguileor, Magda ^a   Tashjian Jr , Armen H ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cell differentiation; p21Waf1 Cip1; p53; PKC; Protein kinase C delta; Tumor suppression

Indexed keywords

ALKALINE PHOSPHATASE; COMPLEMENTARY DNA; PROTEIN KINASE C DELTA; PROTEIN P21; PROTEIN P50; VIRUS VECTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARBOXY TERMINAL SEQUENCE; CARCINOGENICITY; CELL COMMUNICATION; CELL SURFACE; COLON CANCER; GENETIC TRANSDUCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICROVILLUS; MITOSIS INDEX; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; TUMOR DIFFERENTIATION; WART VIRUS;

BLOTTING, WESTERN; CELL DIFFERENTIATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 8644283646     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20535     Document Type: Article

References (41)

1. Craven PA, DeRubertis FR. Alterations in protein kinase C in 1,2-dimethylhydrazine induced colonic carcinogenesis. Cancer Res 1992;52:2216-21.
2. Kopp R, Noelke B, Sauter G, Schildberg FW, Paumgartner G, Pfeiffer A. Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res 1991;51:205-10.
3. Levy MF, Pocsidio J, Guillem JG, Forde K, LoGerfo P, Weinstein IB. Decreased levels of protein kinase C enzyme activity and protein kinase C mRNA in primary colon tumors. Dis Colon Rectum 1993;36:913-21.
4. McGarrity TJ, Peiffer LP. Protein kinase C activity as a potential marker for colorectal neoplasia. Dig Dis Sci 1994;39:458-63.
5. Craven PA, DeRubertis FR. Loss of protein kinase C delta isozyme immunoreactivity in human adenocarcinomas. Dig Dis Sci 1994;39:481-9.
6. Brasitus TA, Bissonnette M. PKC isoforms: villains in colon cancer? Gastroenterology 1998;115:225-7.
7. Black JD. Protein kinase C isozymes in colon carcinogenesis: guilt by omission. Gastroenterology 2001;20:1868-72.
8. Perletti GP, Marras E, Concari P, Piccinini F, Tashjian AH Jr. PKC-delta acts as a growth and tumor suppressor in rat colonic epithelial cells. Oncogene 1999;18:1251-6.
9. Cerda SR, Bissonnette M, Scaglione-Sewell B, Lyons MR, Khare S, Mustafi R, Brasitus TA. PKC-delta inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apoptosis in CaCo-2 cells. Gastroenterology 2001;120:1700-12.
10. Watanabe T, Ono Y, Taniyama Y, Hazama K, Igarashi K, Ogita K, Kikkawa U, Nishizuka Y. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc Natl Acad Sci USA 1992;89:10159-63.
11. Fukumoto S, Nishizawa Y, Hosoi M, Koyama H, Yamakawa K, Ohno S, Morii H. Protein kinase C delta inhibits the proliferation of vascular smooth muscle cells by suppressing G1 cyclin expression. J Biol Chem 1997;272:13816-22.
12. Mischak H, Goodnight J, Kolch W, Martiny-Baron G, Schaechtele C, Kazanietz MG, Blumberg, PM, Pierce JH, Mushinski JF. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem 1993;268:6090-6.
13. Mishima K, Ohno S, Shitara N, Yamaoka K, Suzuki K. Opposite effects of the overexpression of protein kinase C gamma and delta on the growth properties of human glioma cell line U251 MG. Biochem Biophs Res Commun 1994;201:363-72.
14. Harrington EO, Loffler J, Nelson PR, Kent KC, Simons M, Ware JA. Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells. J Biol Chem 1997;272:7390-7.
15. Bharti A, Kraeft SK, Gounder M, Pandey P, Jin S, Yuan ZM, Lees-Miller SP, Weichselbaum R, Weaver D, Chen LB, Kufe D, Kharbanda S. Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis. Mol Cell Biol 1998;18:6719-28.
16. Kielbassa K, Muller HJ, Meyer HE, Marks F, Gschwendt M. Protein kinase C delta-specific phosphorylation of the elongation factor eEF-alpha and an eEF-1 alpha peptide at threonine 431. J Biol Chem 1995;270:6156-62.
17. Uddin S, Sassano A, Deb DK, Verma A, Majchrzak B, Rahman A, Malik AB, Fish EN, Platanias LC. Protein kinase C-delta (PKC-delta) is activated by type I interferons and mediates phosphorylation of Stal1 on serine 727. J Biol Chem 2002;277:14408-16.
18. Basu A, Woolard MD, Johnson CL. Involvement of protein kinase C-delta in DNA damage-induced apoptosis. Cell Death Differ 2001;8:899-908.
19. Ren J, Datta R, Shioya H, Li Y, Oki E, Biedermann V, Bharti A, Kufe D. p73beta is regulated by protein kinase Cdelta catalytic fragment generated in the apoptotic response to DNA damage. J Biol Chem 2002;277:33758-65.
20. Gschwendt M. Protein kinase C delta. Eur J Biochem 1999;259:555-64.
21. Morgenstern JP, Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucl Acids Res 1990;18:3587-96.
22. Perletti G, Concari P, Giardini R, Marras E, Piccinini F, Folkman J, Chen L. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. Cancer Res 2000;60:1793-6.
23. Mancini M, Anderson BO, Caldwell E, Sedghinasab M, Paty PB, Hockenbery DM. Mitochondrial proliferation and paradoxical membrane depolarization during terminal differentiation and apoptosis in a human colon carcinoma cell line. J Cell Biol 1997;138:449-69.
24. Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001;4:303-13.
25. Baudier J, Delphin C, Grunwald D, Khochbin S, Lawrence JJ. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein. Proc Natl Acad Sci USA 1992;89:11627-31.
26. Mundt M, Hupp T, Fritsche M, Merkle C, Hansen S, Lane D, Groner B. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential. Oncogene 1997;15:237-44.
27. Takenaka I, Morin F, Seizinger BR, Kley N. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J Biol Chem 1995;270:5405-11.
28. Chang BD, Broude EV, Fang J, Kalinichenko TV, Abdryashitov R, Poole JC, Roninson IB. p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells. Oncogene 2000;19:2165-70.
29. Shin BA, Ahn KY, Kook H, Koh JT, Kang IC, Lee HC, Kim KK. Overexpressed human RAD50 exhibits cell death in a p21(WAF1/ CIP1)-dependent manner: its potential utility in local gene therapy of tumor. Cell Growth Differ 2001;12:243-54.
30. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004;23:2825-37.
31. Mischak H, Pierce JH, Goodnight J, Kazanietz MG, Blumberg PM, Mushinski JF. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta. J Biol Chem 1993;268:20110-5.
32. Tian JQ, Quaroni A. Involvement of p21(WAF1/Cip1) and p27(Kip1) in intestinal epithelial cell differentiation. Am J Physiol 1999;276:C1245-58.
33. Frey MR, Saxon ML, Zhao X, Rollins A, Evans SS, Black JD. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21(waf1/cip1) and p27(kip1) and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J Biol Chem 1997;272:9424-35.
34. Frey MR, Clark JA, Leontieva O, Uronis JM, Black AR, Black JD. Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium. J Cell Biol 2000;151:763-78.
35. Niwa K, Inanami O, Yamamori T, Ohta T, Hamasu T, Karino T, Kuwabara M. Roles of protein kinase C delta in the accumulation of P53 and the induction of apoptosis in H2O2-treated bovine endothelial cells. Free Radic Res 2002;36:1147-53.
36. Abbas T, White D, Hui L, Yoshida K, Foster DA, Bargonetti J. Inhibition of human p53 basal transcription by down-regulation of protein kinase Cdelta. J Biol Chem 2004;279:9970-7.
37. Park JW, Jang MA, Lee YH, Passaniti A, Kwon TK. p53-independent elevation of p21 expression by PMA results from PKC-mediated mRNA stabilization. Biochem Biophys Res Commun 2001;12:244-8.
38. Ohnishi K, Wang X, Takahashi A, Ohnishi T. Contribution of protein kinase C to p53-dependent WAF1 induction pathway after heat treatment in human glioblastoma cell lines. Exp Cell Res 1998;238:399-406.
39. Javelaud D, Besançon F. Inactivation of p21WAF1 sensitizes cells to apoptosis via an increase of both p14ARF and p53 levels and an alteration of the Bax/Bcl-2 ratio. J Biol Chem 2002;277:37949-54.
40. Rodrigues NR, Rowan A, Smith ME, Kerr IB, Bodmer WF, Cannon JV, Lane DP. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-9.
41. Pochampally R, Fodera B, Chen L, Lu W, Chen J. Activation of an MDM2-specific caspase by p53 in the absence of apoptosis. J Biol Chem 1999;274:15271-7.